Checkpoint therapeutics, inc. (CKPT)
Income statement / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Sep'15Dec'14
Revenue - related party

2,328

1,708

4,714

4,439

3,515

3,506

807

1,151

1,375

1,725

1,891

2,088

2,986

2,570

2,097

0

0

0

0

Operating expenses:
Research and development

17,379

19,325

26,016

29,970

31,303

33,654

25,149

22,256

22,309

19,081

21,908

21,666

21,606

20,267

16,009

0

0

0

0

General and administrative

7,208

7,233

6,583

6,507

6,101

6,592

6,445

6,245

6,210

5,419

5,154

4,782

4,686

4,467

3,596

0

0

0

0

Total operating expenses

24,587

26,558

32,599

36,477

37,404

40,246

31,594

28,501

28,519

24,500

27,062

26,448

26,292

24,734

19,605

0

0

0

0

Loss from operations

-22,259

-24,850

-27,885

-32,038

-33,889

-36,740

-30,787

-27,350

-27,144

-22,775

-25,171

-24,360

-23,306

-22,164

-17,508

0

0

0

0

Other income
Interest income

154

136

153

168

172

148

121

100

85

98

89

78

67

47

35

0

0

0

0

Other income

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

Interest expense and debt amortization

-

-

-

-

-

-

-

-

-

-

-

-

-

344

414

0

0

0

0

Change in fair value of warrant liabilities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Total other income

154

136

378

393

397

373

121

100

85

98

89

78

67

-297

-379

0

0

0

0

Net Loss

-22,105

-24,714

-27,507

-31,645

-33,492

-36,367

-30,666

-27,250

-27,059

-22,677

-25,082

-24,282

-23,239

-22,461

-17,887

0

0

0

0

Loss per Share:
Basic and diluted net loss per common share outstanding

-0.06

-0.22

-0.15

-0.15

-0.18

-0.37

-0.32

-0.23

-0.35

-0.26

-0.26

-0.28

-0.20

-0.38

-0.24

-0.25

-0.17

-0.44

0.00

Basic and diluted weighted average number of common shares outstanding

50,875

41,705

34,561

32,704

32,243

31,169

29,249

29,044

24,751

22,883

22,801

22,731

22,059

21,875

21,798

21,728

20,775

8,528

8,000